BioBridges Competitors

ARG is now part of Evestia Clinical. Follow Evestia Clinical's page to stay connected with our experienced team, our insights and opportunities in trial development. The new organization forms a leading mid-tier CRO with expanded global reach, enhanced therapeutic expertise, and a full-service clinical trial offering. ARG, founded in 2004, is a contract research organization focused on oncology, immunology, and neurology, providing comprehensive clinical program development services ranging from planning to commercialization, and achieving over 50 market authorizations to date. Built on the vision that every project should be highly individualized, ARG has experienced consistent global growth, expanding its range to include drug and device strategic consulting, clinical trial management services, and advanced clinical data and analytic solutions. ARG uses first-in-class technology platforms along with relationship-driven flexibility to optimize clinical studies, because we believe everyone deserves to be well.

Ce3 is a full-service CRO committed to working with biotechnology companies on emerging therapies and technologies to improve patient lives. Our experience in working exclusively with Biotechs has refined and leveraged our tools and skills to easily accommodate the special requests and customization required by this dynamic environment. Our focus is on early phase development. We know the level of agility, detail, and precision such studies require. Ce3 supports clients in the most cost-effective manner with quality data to facilitate timely decision making. We can execute faster, easier, and better to meet biotech and investor needs. Ce3’s depth of experience includes Immuno-Oncology (inclusive of CAR-T), Gene Therapy (multiple therapeutic indications), and other innovative therapies. Our expertise is in Oncology clinical research and clinical trial execution: • First in Human • Dose Escalation • Cohort Management • Complex and adaptive study designs Our name, Ce3, represents our core values and serves as the foundation of our operations: a collaborative approach in managing your studies while delivering experience, efficiency and excellence!

Over 15 years ago, Peachtree was founded to fill a perceived missing principle in typical CRO services. Where can I find a CRO that will partner with me, understand my challenges, and solve issues to keep my program on track? Filling this need requires experienced clinical research professionals. We focused on people – building an organization by investing in highly experienced personnel with broad therapeutic area expertise in a number of clinical trials. From single-center Phase I to global multi-center trials. Most all of our clinical personnel have both sponsor and CRO experience – allowing us to fully understand the issues our sponsor-clients face. We built a rock-solid processes and systems infrastructure to support the teams and this investment continues today – always seeking to improve our service. We also saw the opportunity to support an under-served segment of the market – emerging mid-sized companies. We felt they could benefit from access to highly-experienced teams that understand the challenges of limited resources and be flexible, reliable, and responsive. Most of all – provide solutions. So where is Peachtree today? 🍑 A full-service CRO offering project management, feasibility & subject recruitment, clinical site management & monitoring, data management, biostatistics, medical monitoring, medical writing, and clinical quality assurance 🍑 We are 80+ highly-experienced clinical research professionals with an average of more than 20 years relevant clinical experience 🍑 Our client roster continues to grow having worked with nearly 100 pharmaceutical, biotech, and medical device companies providing full-service clinical trial support to niche services 🍑 Continued investment in best-in-class systems such as IBM Clinical for EDC, Veeva Vault for eTMF, ZenQMS for quality management and training, and Oracle for CTMS.